Form 4: Guardant Health Director Sells Shares

Sentiment:

Insider Transaction (Form 4)


Steve E. Krognes, a Director of Guardant Health, Inc., sold 6,674 shares of common stock on September 16, 2026.

Summary

  • Open-market sale: disposed of 1,103 Common Stock at $174.46 ($192,432) on September 16, 2026; holds 13,477 after (Direct).
  • Open-market sale: disposed of 3,300 Common Stock at $175.42 ($578,888) on September 16, 2026; holds 10,177 after (Direct).
  • Open-market sale: disposed of 1,300 Common Stock at $176.34 ($229,236) on September 16, 2026; holds 8,877 after (Direct).
  • Open-market sale: disposed of 971 Common Stock at $177.48 ($172,330) on September 16, 2026; holds 7,906 after (Direct).

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,172,886 of stock on the open market.

Insider Transactions

Steve E. Krognes — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-09-16Open-market saleCommon Stock1,103$174$192.4K13,477
2026-09-16Open-market saleCommon Stock3,300$175$578.9K10,177
2026-09-16Open-market saleCommon Stock1,300$176$229.2K8,877
2026-09-16Open-market saleCommon Stock971$177$172.3K7,906

Key Dates

DateDescription
2026-09-16Open-market sale (1,103 shares)
2026-09-16Open-market sale (3,300 shares)
2026-09-16Open-market sale (1,300 shares)
2026-09-16Open-market sale (971 shares)

Keywords

insider transaction, Form 4, GH, Guardant Health, Inc., bearish, Steve E. Krognes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.